Market Highlights: A membrane oxygenator is a device that is used for the purpose of adding oxygen to, and further removing carbon dioxide from the blood. It can be mainly used in two primary modes, firstly to replicate the function of the lungs during the cardiopulmonary bypass (CPB), and secondly to oxygenate the blood for a longer term of life support, which is termed to be as extracorporeal membrane oxygenation, i.e. ECMO. A membrane oxygenator generally consists of a very thin gas permeable membrane that separates the blood and the gas flows inside the CPB circuit; furthermore, oxygen is diffused from the gas side into the blood, as well as carbon dioxide is diffused from the blood into the gas for the purpose of disposal. These membrane oxygenators can be further be classified into two types namely, the flat sheet and the hollow fiber membrane oxygenators. These segments of the membrane oxygenators are hereby expected to hold a highly dominant market share during the forecasted period owing to the fact that they cause comparatively less blood trauma, less hemolysis, and also less post-operative bleeding. Membrane oxygenators also have the advantage of decreasing the damage as well as thrombosis which is usually seen while using the bubble oxygenators. Hence, these all factors are thereby expected to boost the market near future. The market study is being classified by Type (Flat Sheet Membrane Oxygenators and Hollow Fiber Membrane Oxygenators), by Application (Hospitals, Clinics and Others) and major geographies with country level break-up that includes South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
Key Players: The prominent players in the Membrane Oxygenator are Medtronic (Ireland), Terumo Cardiovascular Systems (United States), Medos AB (Sweden), Sorin Group (Italy), LivaNova Plc (United Kingdom), Microport (China), Nipro (Japan), Chalice Medical Limited (United Kingdom), Braile Biomedica (Brazil), Maquet (Germany) and Wego New Life Medical Devices (China).
Major Market Development Highlights On 14 Feb 2018, LivaNova Plc, which a leading medical technology company, had announced the acquisition of TandemLife, which was a privately held company that mainly focused on advanced cardiopulmonary temporary support solutions.
Key Questions Answered in the Report What will the Membrane Oxygenator Market size and the growth rate be in Future? What are the key factors driving the Membrane Oxygenator Market? What are the key market trends and macro-economic impacting the growth of the Membrane Oxygenator Market? What are the challenges to market growth? Who are the key vendors in the Membrane Oxygenator Market? What are the market opportunities and threats faced by the vendors in the Membrane Oxygenator Market? Trending factors influencing the market shares of the Players. What are the key outcomes of the five forces analysis of the Membrane Oxygenator Market?
Research Methodology: The top-down and bottom-up approaches are used to estimate and validate the size of the Global Membrane Oxygenator market. In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Membrane Oxygenator market. In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc. Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Manufacturers of Membrane Oxygenator, Suppliers and Distributors of Membrane Oxygenator, End-Users, Potential Investors, Market Research Firms, Regulatory Bodies and Others. This helps us to gather the data for the players revenue, operating cycle and expense, profit along with product or service growth etc. Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, Annual reports, press releases etc.